Targeted treatment with the fibroblast growth factor receptor (FGFR) inhibitor erdafitinib improved responses and overall survival compared to standard chemotherapy for patients with metastatic urothelial cancers with FGFR ...
Oct 23, 2023
0
0
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone ...
Oct 23, 2023
0
76
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously ...
Oct 22, 2023
0
1
Knee and hip replacements are increasing globally due to an aging population. In the United States, the number of patients needing a joint replacement will exceed 2.7 million in the next seven years. Post-surgery infections, ...
Oct 18, 2023
0
90
Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard ...
Oct 18, 2023
0
44
Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports.
Oct 18, 2023
0
55
Mosquito-transmitted virus infections are on the rise and their spread is accelerating in Texas, Florida and elsewhere in the American South. With the rise of mosquito-borne illnesses, infectious disease experts at Baylor ...
Oct 17, 2023
0
15
An investigational drug, encaleret, restored calcium levels in people with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic disorder marked by an imbalance of calcium in the blood and urine, as well as abnormally ...
Oct 13, 2023
0
22
A new study endorses closed-loop use in type 1 diabetes pregnancy and highlights how the technology can facilitate positive pregnancy experiences. The study is published in Diabetes Technology & Therapeutics (DTT).
Oct 12, 2023
0
1
For HIV-positive adults with tuberculous meningitis, adjunctive dexamethasone does not confer a benefit with respect to survival, according to a study published in the Oct. 12 issue of the New England Journal of Medicine.
Oct 12, 2023
0
6
